Radiotherapy-chemotherapy combinations in head and neck squamous cell carcinoma: Overview of randomized trials

Anticancer Research

Volumn 16, Issue 4 C, 1996, Pages 2397-2402

  Bourhis, J ^a   Eschwege, F ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Chemotherapy; Head and neck squamous cell carcinoma; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN; MITOMYCIN C; VINBLASTINE;

CANCER ADJUVANT THERAPY; CANCER SURVIVAL; HEAD AND NECK CANCER; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0029791564     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (78)

1. Dimery JW, Wong WK: Overview of combined modality therapy for head and neck cancer. JNCI 85: 95-111, 1993.
2. Munro AJ: An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 71: 83-91, 1995.
3. Hussey D, Abrams J: Combined therapy in advanced head and neck cancer hydroxyurea and radiotherapy. Prog Clin Cancer 6: 79-86, 1975.
4. Richards G, Chambers R: Hydroxyurea: a radiosensitizer in the treatment of neoplasms of head and neck. Am J Roentgen 105: 555-565, 1969.
5. Stefani S, Eells R, Abbate J: Hydroxyurea and radiotherapy in head and neck cancer. Result of a prospective controlled study in 126 patients. Radiology 101: 391-396, 1971.
6. Eschwege F, Sancho-Garnier H, Gerard JP, et al: Ten-year results of a randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the EORTC. NCI Mongraph 275-278, 1988.
7. Fu K, Phillips T, Silverberg I, et al: Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology GroupRandomized trial. J Clin Oncol 5: 1410-1418, 1987.
8. Morita K: Clinical significance of radiation therapy combined with chemotherapy. Strahlentherapie 156: 228-233, 1980.
9. Shanta V, Krishnamurthi S: Combined bleomycin and radiotherapy in oral cancer. Clin Radiol 31: 617-20, 1980.
10. Shetty P, Mehta A, Shinde A, Mazumdar A, Mingorani C: Controlled study in squamous cell carcinoma of base of tongue using conventional radiation, radiation with single drug and radiation with multiple drug chemotherapy. Proc Am Soc Clin Oncol 5: 595 (abstr), 1985.
11. Vermund H, Kaalhus O, Winther F, et al. Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: a phase III clinical trial. Int J Radiat Oncol Biol Phys 11: 1877-86, 1985.
12. Kapstad B, Bang G, Rennaes S, Dahler A: Combined preoperative cobalt and bleomycin in patients with head and neck carcinoma. A controlled clinical study. Int J Radiat Oncol Biol Phys 4: 85-89, 1978.
13. Parvinen L, Parvinen E, Nordman E Kortekangas: Combined bleomycin treatment and radiation therapy in squamous cell carcinoma of the head and neck region. Acta Radiol Oncol 24: 487-490, 1985.
14. Gupta N, Pointon R, Wilkinson P: A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously. Clin Radiol 38: 575-581, 1987.
15. Lo T, Wiley A, Ansfield F: Combined radiation therapy and 5FU for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study. Am J Roentgen 126: 229-35, 1976.
16. Sanshiz F, Milla A, Torner J, et al: Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 19: 1347-1350, 1990.
17. Browman G, Hodson I, Levine M et al: Placebo-controlled randomized trial of iv infusional 5-fluorouracil concurrent with standard radiotherapy in stage III and IV head and neck. Proc Am Soc Clin Oncol 12: 891 (abstr), 1993.
18. Haselow R, Warshaw M, Oken M et al: Radiation alone versus radiation with weekly low dose cisplatinum in unresectable cancer of the head and neck. In: Head and neck cancer vol II Fee WE. Goepfert H, Johns M, eds Philadelphia pp 279-81, 1990.
19. Keane T, Cummings B, O'Sullivan B et al: A randomised trial of radiation therapy compared to split course radiation therapy combined with mitomycinC and 5-fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 25: 613-618, 1993.
20. Nissenbaum M, Browde S, Bezwoda W et al: Treatment of advanced head and neck cancer: multiple daily dose fractionated radiation therapy and sequential multimodal treatment approach. Med Pediatr Oncol 12: 204-208, 1984.
21. Salvajoli J, Morioka H, Trippe N, Kowalski: A randomized trial of neoadjuvant versus concomitant versus radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma. Eur Arch Otorhinol Laryngol 249: 211-215, 1992.
22. Weissler M, Melin S, Sailer S et al. Simultaneous chemoradiation in the treatment of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 118: 806-810, 1992.
23. Boidi-Trotti A, Rovea P, Gabrielle AM et al: Utilizzazione del cisplatino come radiosensibilizzante nei tumori avanzati della regione testa-collo studio randomisato. Radiol Med 82: 504-507, 1991.
24. Haddad E, Mazeron JJ, Vergnes L, et al: Concurent radiochemotherapy in advanced head and neck cancer: preliminary results of a phase III trial. Proc Am Soc Clin Oncol 11: 775 (abstr), 1992.
25. Merlano M, Vitale V, Rosso R et al: Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Eng J Med 327: 1115-1121, 1992.
26. Weissberg J, Son Y, Papac R, et al: Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys 17: 3-9, 1989.
27. Haffty B, Son Y, Sasaki C, et al: Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. Int Radiat Oncol Biol Phys 27: 241-250, 1993.
28. Bachaud JM, David JM, Boussin G, Daly Nr: Combined post operative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomised trial. Int J Radiat Oncol Biol Phys 20: 243-46, 1991.
29. Archangeli G, Nervi C, Righini R et al: Combined radiation and drugs: the effect of intra-arterial chemotherapy followed by radiotherapy in head and neck cancer. Radioth Oncol 1: 101-107, 1983.
30. Fazekas J, Sommer C, Kramer S, et al: Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx. Concluding reports of an RTOG randomized trial on 638 patients. Int 1 Radiat Oncol Biol Phys 6: 533-541, 1980.
31. Petrovitch Z, Block J, Kuisk H, et al: A randomized comparison of radiotherapy with a radiotherapy-chemotherapy combination in stage IV carcinoma of head and neck. Cancer 47: 2259-2264, 1981.
32. Knowlton A, Percarpio B, Bobrow S, Fischer J: Methotrexate and radiation therapy in the treatment of advanced head and neck tumors. Radiology 116: 709-712, 1975.
33. Tepmongkol P: Large intravenous dose of methotrexate and radiotherapy in the treatment of advanced oral cancers. J Med Ass Thailand 62: 17-24, 1979.
34. von Essen C, Joseph L, Simon G, Singh A, Singh S: Sequential chemotherapy and radiation therapy of buccal mucosa carcinoma in South India. 102: 530-540, 1968.
35. Richard JM, Sancho H, Lepintre Y, Rodary C, Pierquin B: Intraarterial methotrexate chemotherapy and telecobalt therapy in cancer of the oral cavity and oropharynx. Cancer 34: 491-96, 1974.
36. Brunin F, Rodriguez J, Jaullery C et al: Induction chemotherapy in advanced head and neck cancer Acta Oncologica 28: 61-65, 1989.
37. Jaullery C, Rodriguez J, Brunin F et al: Induction chemotherapy in advanced head and neck tumors: results of two randomised trials. Int J Radiat Oncol Biol Phys 23: 483-489, 1992.
38. Tejedor M, Murias A, Soria P, et al: Induction chemotherapy with carboplatin and floratur in advanced head and neck cancer. A randomized study. Am J Clin Oncol 15: 417-421, 1992.
39. Amer M, Bull C, Daouk N, McArthur P: A prospective randomized trial of chemotherapy with platinum vincristine & bleomycin followed by radiotherapy versus radiotherapy alone for advanced head and neck cancer. Proc Am Soc Clin Oncol 3: 625 (abstr), 1983.
40. Szpirglas H, Nizri D, Marneur M Lacoste JP, Benslama L: Neoajuvant chemotherapy A randomized trial before radiotherapy in oral and oropharyngeal carcinoma: end results. In Proceeding of the second International Conference on head and neck cancer. 1987, Kugler and Ghedini Arlington Va pp 261-64, 1988.
41. Luboinski B: Personal communication on behalf of the GETTEC (Groupe d'Etude des Tumeurs de la Tête Et du Cou) Paris.
42. Paccagnella A, Orlando A, Marchlori C, et al: A phase III trial of neoadjuvant chemotherapy in head and neck cancer. Proc Am Soc Clin Oncol 12: 894 (Abstr), 1993.
43. Bezwoda W, De Moor N, Derman D et al: Treatment of advanced head and neck cancer by means of radiation therapy plus chemotherapy. A randomised trial. Med Pediat Oncol 6: 353-358, 1979.
44. Stell P, Dalby J, Strickland, et al: Sequential chemotherapy and radiotherapy in advanced head and neck cancer. Clin Radiol 34: 463-467, 1983.
45. Depondt J, Gehanno P, Martin M et al: Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer. Oncology 50: 23-27, 1993.
46. Wolf G: on behalf of the Veteran Affairs Laryngeal Cancer Study Group (VALCSG). Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Eng J Med 324: 1685-1690, 1992.
47. Luboinski B: Personal communication on behalf of the GETTEC (Groupe d'Etude des Tumeurs de la Tête Et du Cou) Paris.
48. Lefèbvre JL, Salmon T: Larynx preservation in hypopharynx squamous cell carcinoma: preliminary results of a randomized study (EORTC). Proc Am Soc Clin Oncol 13: 283 (Abstr), 1994.
49. Adelstein O, Sharan V, Earle S et al: Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer Cancer 65: 1685-1691, 1990.
50. Merlano M, Rosso R, Sertoli M, et al: Randomized comparison of two chemotherapy, radiotherapy scheme for stage III and IV unrescectable squamous cell carcinoma of the head and neck. Laryngoscope 100: 531-542, 1990.
51. Taylor S, Murthy A, Vannetzel JM, et al: Randomized comparison of neoadjuvant cisplatinum and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol 12: 385-395, 1994.
52. SEGOG: A randomized trail of combined multidrug chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck. Eur J Surg Oncol, 12: 289-295, 1986.
53. Carugati A, Pradier R: Combination chemotherapy pre-radical treatment for head and neck squamous cell carcinoma. Proc Am Soc Clin Oncol 7: 589 (abstr), 1988.
54. Domenge C, Marandas P, Vignoud J, et al: Post Surgical adjuvant chemotherapy in extra capsular spread invaded lymph node (N+R+ of epidermoid carcinoma of the head and neck. A randomized multicentric trial. Second International Conference on Head and Neck Cancer Boston 1988. Am Soc Head Neck Surg 74, 1988.
55. Ervin T, Clark J, Weichselbaum R, et al: An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous cell carcinoma of the head and neck. J Clin Oncol 5: 10-20, 1987.
56. Head and Neck Contract Program: Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the head and neck contracts program. Cancer 60: 301-311, 1987.
57. Laramore G, Scott C, Al-Sarrf M et al: Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on intergroup study 0034. Int J Radiat Oncol Biol Phys 23: 705-713, 1992.
58. Jortay A, Demard F, Dalesio O, et al: A randomized EORTC study on the effect of preoperative polychemotherapy in piriform sinus carcinoma treated by pharyngolaryngectomy and irradiation. Results from 5 to 10 years. Acta Chir Belg 90: 115-122, 1990.
59. Hasewaga Y, Matsuura H, Fukushima M: A randomized trial of neoadjuvant chemotherapy in advanced head and neck carcinomas. Proc ASCO: 13, 286, 1994.
60. Horiuchi M, Inuyama Y, Miyake H: Adjuvant chemotherapy for recectable squamous vell carcinomas of the head and neck: report on intergroup study 0034. Int J Radiant Oncol Biol Phys 23: 705-713, 1992.
61. Kun L, Toohil R, Holoye P et al: A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 12: 173-178, 1986.
62. Martin M, Hazan A, Vergnes L, et al: Randomized study of 5 fluorouracil and cisplatin as neoadjuvant therapy in head and neck cancer: a preliminary report. Int J Radiat Oncol Biol Phys 19: 973-975, 1990.
63. Mazeron IJ, Martin M, Brun B, et al: Induction chemotherapy in head and neck cancer: result of a phase III trial. Head and Neck 14: 85-91, 1992.
64. Pearlman N, Iohnson B, Braun T et al: A prospective study of preoperative chemotherapy and split-course irradiation for locally advanced or recurrent oral/pharyngeal squamous carcinoma. Am J Clin Oncol 8: 490-496, 1985.
65. Rentschler R, Wilbur D, Petti G et al: Adjuvant methotrexate escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas a prospective randomised study. J Clin Oncol 5: 278-885, 1987.
66. Richard JM, Kramar A, Molinari R, et al: Randomized EORTC head and neck cooperative group of pre-operative intra-arterial chemotherapy in oral cavity and oropharynx carcinoma. Eur J Cancer 27: 821-827, 1991.
67. Schuller D, Metch B, Stein D, et al: Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest oncology group. Laryngoscope 98: 1205-1211, 1988.
68. Stolwijk C, Wagener D, Vanden Broeck P, et al: Randomized neoadjuvant chemotherapy trial for advanced head and neck cancer. Neth J Med 28: 347-351, 1985.
69. Szpirglas H, Nizri D, Lacoste JP: Neo adjuvant chemotherapy for patients with oral and oropharyngeal T3/T4 carcinomas Proc. Third Congress on neoadjuvant chemotherapy. Banzet P. Eds Springer Verlag Berlin: 13-18, 1991.
70. Gedouin D, Desprez P, Perron, IJ: Personal communication.
71. Taylor S, Applebaum E, Showel J, et al: A randomized trial and adjuvant chemotherapy in head and neck cancer. J Clin Oncol 3: 672-679, 1985.
72. Tejada F, Chandler J: Combined therapy for stage III and IV head and neck cancer. Proc Am Soc Clin Oncol 774 (Abstr), 1982.
73. Toohill R, Anderson T, Byhard R et al: Cisplatin and Fluorouracil as neoadjuvant therapy in head and neck cancer: a preliminary report. Arch Otolaryngol Head Neck Surg 113: 758-761, 1987.
74. Pignon JP, Bourhis J, Domenge C: Meta-analysis of chemotherapy in head and neck cancer: individual data versus data of the literature. Br Cancer 72: 1063, 1995.
75. Bourhis J, Fortin A, Dupuis O, Lusinchi A, Mamelle G, Schwaab G, Armand JP, Luboinski B, Malaise EP, Eschwege F, Wilbaut P: Very accelerated radiotherapy: preliminary results in locally unresectable head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 32: 747-752, 1995.
76. Bourhis J, Wilbaut P, Eschwege E: Very accererated fractionation. Int J Radiat Oncol Biol Phys 32: 1266-1267, 1995.
77. Leyvraz S, Pasche P, Bauer J, Bernasconi S: Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced HNSCC: 4-year results of a phasel/II study. J Clin Oncol 12: 1876-1885, 1994.
78. Bourhis J, Wilson G, Bosq J, Janot F, Wibault P, Luboinski B, Eschwege F, Malaise EP: Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer. The Laryngoscope 104: 468-472, 1994.